New implant could replace eye drops after corneal surgery
NCT ID NCT06235567
First seen Mar 30, 2026 · Last updated May 14, 2026 · Updated 5 times
Summary
This study tests if a tiny steroid implant placed in the tear duct works as well as standard steroid eye drops for managing inflammation after corneal crosslinking surgery for keratoconus. About 20 people aged 13 and older with progressive keratoconus will be enrolled. The implant delivers medication over 30 days and dissolves on its own, which may help patients who struggle with using eye drops regularly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KERATOCONUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mission Bay Hospital
San Francisco, California, 94158, United States
-
UCSF Pediatric Ophthalmology
San Francisco, California, 94158, United States
-
Wayne and Gladys Center for Vision
San Francisco, California, 94158, United States
Conditions
Explore the condition pages connected to this study.